Emmessar Biotech Clarifies SEBI Circular Compliance
Emmessar Biotech & Nutrition Ltd has published newspaper advertisements in 'The Free Press Journal' and 'Navshakti' regarding a special window for re-lodgement of physical share transfer requests, in compliance with SEBI Circular No. SEBI/HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026. The company also noted that no such requests were received, and reporting to SEBI has been completed by their Registrar and Transfer Agent, MUFG Intime India Private Limited, as per SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97. Separately, a notice for auction sale of immovable assets under the SARFAESI Act, 2002, was published for recovery of dues amounting to ₹93,15,47,177 from Goldenera Flour & Food Industry Pvt.Ltd and others.
Key Highlights
- Company complied with SEBI circular on physical share re-lodgement.
- No requests for re-lodgement of physical shares were received.
- SEBI reporting completed by Registrar and Transfer Agent.
- Separate auction notice published for recovery of ₹93.15 Crore debt.
Price Impact
More from EMMESSA